Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus

The clinical trial of allogenic mesenchymal stem cells (MSCs) transplantation for refractory SLE patients has shown significant safety and efficacy profiles. However, the optimum frequency of the MSCs transplantation (MSCT) is unknown. This study was undertaken to observe whether double transplantat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wang, Dandan, Akiyama, Kentaro, Zhang, Huayong, Yamaza, Takayoshi, Li, Xia, Feng, Xuebing, Wang, Hong, Hua, Bingzhu, Liu, Bujun, Xu, Huji, Chen, Wanjun, Shi, Songtao, Sun, Lingyun
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3399403/
https://ncbi.nlm.nih.gov/pubmed/22829849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/273291
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares